Their pricing for X was always F'd up IMHO . My wife rounds dialysis clinics and is authorized to prescribe and she said ...I can prescribe X but most of my patients are Medicare / Medicaid and none of them are willing to pay the monthly copay ...which I estimated to be at least $700 - $900 a mth .
My guess is the Co hopes to get the monthly copay down to around $400 a mth . It's probably around $600 a month using the current coupon for non Medicare patients . More sales but less profit per sale ...helped by passage of legislation before Congress .
Wether patients are willing to pay $400 a mth rather then trying to tolerate current generic binders ( low cost ) ...remains to be seen
But Co must be trading almost at the IBSRELA value alone at these levels. IBSRELA scripts are strong and copay more reasonable for a population that is usually younger and working age
Market Data 
Markets 
AI
